1313513-03-9

Basic information

• Product Name: (2S,3R,4R,5S,6R)-2-(4-chloro-2-methoxy-5-((5-(thiophen-3-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol
• Synonyms: (2S,3R,4R,5S,6R)-2-(4-chloro-2-methoxy-5-((5-(thiophen-3-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol
• CAS NO: 1313513-03-9
• Molecular Weight: 483.994
• Mol File: 1313513-03-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (2S,3R,4R,5S,6R)-2-(4-chloro-2-methoxy-5-((5-(thiophen-3-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,3R,4R,5S,6R)-2-(4-chloro-2-methoxy-5-((5-(thiophen-3-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol(1313513-03-9)
• EPA Substance Registry System: (2S,3R,4R,5S,6R)-2-(4-chloro-2-methoxy-5-((5-(thiophen-3-yl)thiazol-2-yl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol(1313513-03-9)

Safety Data

• Hazardous Substances Data: 1313513-03-9(Hazardous Substances Data)

Upstream product

• 1259020-48-8 5-bromo-2-chloro-4-methoxybenzoic acid 
• 1259020-79-5 5-bromo-2-chloro-4-methoxybenzonitrile 
• 1259020-54-6 2-(2-chloro-4-methoxy-5-((2S,3S,4R,5R,6R)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)-tetrahydro-2H-pyran-2-yl)phenyl)acetic acid 
• 1313512-94-5 C₄₂H₄₂BrClO₆ 
• 1313512-93-4 2-(2-chloro-4-methoxy-5-((2S,3S,4R,5R,6R)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)-tetrahydro-2H-pyran-2-yl)phenyl)acetonitrile 
• 1313512-92-3 (2-chloro-4-methoxy-5-((3S,4R,5R,6R)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)tetrahydro-2H-pyran-2-yl)benzyloxy)triisopropylsilane 
• 1313512-91-2 (2-chloro-4-methoxy-5-((3S,4R,5R,6R)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)tetrahydro-2H-pyran-2-yl)phenyl)methanol 
• 1259020-46-6 5-bromo-2-chloro-4-hydroxybenzonitrile 
• 1259020-50-2 (5-bromo-2-chloro-4-methoxybenzyloxy)triisopropylsilane 
• 1033723-31-7 (5-bromo-2-chloro-4-methoxyphenyl)methanol 
• 85210-58-8 N-[(thien-3-ylcarbonyl)methyl]amine hydrochloride 
• 3336-16-1 2-chloro-4-hydroxybenzonitrile 

Relevant articles and documents

THIAZOLE DERIVATIVES AS SGLT2 INHIBITORS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

The present invention relates to a novel compound with thiazole ring having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney, and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes.